ALLISON POPE: Open Payments
NPI 1588189609 · SOUTH BOSTON, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$879 in 45 payments from 14 companies in 2025. Trend: 2023 $1,069 · 2024 $1,143 · 2025 $879
Food & beverage: $879
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 16 | $339 |
| Lilly USA, LLC | 5 | $85 |
| Exact Sciences Corporation | 3 | $73 |
| AstraZeneca Pharmaceuticals LP | 4 | $64 |
| ABBVIE INC. | 3 | $52 |
| PFIZER INC. | 3 | $48 |
| Dexcom, Inc. | 2 | $37 |
| Inspire Medical Systems, Inc. | 1 | $36 |
| Merck Sharp & Dohme LLC | 2 | $34 |
| Baxter Healthcare | 1 | $26 |
Products named: Wegovy, MOUNJARO, Rybelsus, VRAYLAR, Cologuard Collection Kit, AIRSUPRA, Dexcom G6 Transmitter, INSPIRE.
Industry payments across VA — which companies pay providers there.
